You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/112314
Title: 
Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injection
Author(s): 
Institution: 
Universidade Estadual Paulista (UNESP)
ISSN: 
0392-856X
Sponsorship: 
  • UNESP (BAAE III)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Sponsorship Process Number: 
CNPq: 301644/2010-1
Abstract: 
Objectives: Steroid joint injection is indicated as starting treatment for juvenile idiopathic arthritis, but its effect as single treatment has not been explored. Our aim was to estimate arthritis remission probability after single or repeated injections.MethodsConduct a retrospective analysis of inactive arthritis status, remission on medication and remission off medication, estimating cumulative probability and mean time to survival, from the first joint injection session to the last follow-up visit or disease-modifying anti-rheumatic drugs initiation. Remission and time to achieve remission status after single or repeated injections were compared.ResultsSeventy-seven patients with 4-year medium follow-up and 254 treated joints, were reviewed. Eighty-three percent of the individuals had oligoarticular subtype and 57% had persistent oligoarticular course. Overall, 26% achieved remission off medication status, 4% remission on medication and 38% initiated disease-modifying anti-rheumatic drugs. Survival analysis resulted in mean time of achieving inactive disease status, remission on medication and off medication of 8, 11 and 56 months, respectively. The cumulative probability of remission off medication was 2% at 12 months, 8% at 24 months and 18% at 36 months. Frequency of inactive disease, remission on medication and remission off medication status decreased proportionally following repeated joint injections in comparison with the frequency of the same status for those receiving single treatment.ConclusionThe dropout rates due to anti-rheumatic drugs initiation indicated limited long-term benefits of intra-articular steroids for juvenile idiopathic arthritis.
Issue Date: 
1-Mar-2014
Citation: 
Clinical and Experimental Rheumatology. Pisa: Clinical & Exper Rheumatology, v. 32, n. 2, p. 291-296, 2014.
Time Duration: 
291-296
Publisher: 
Clinical & Exper Rheumatology
Keywords: 
  • juvenile idiopathic arthritis
  • remission
  • triamcinolone hexacetonide
Source: 
http://www.clinexprheumatol.org/a.asp?IDArchivio=155
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/112314
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.